Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,999,679
+$508,079 QoQ
Shares Held
35,436
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#1,179
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWNSQUARE CAPITAL LLC holds $34,376,072 across 12 Drug Manufacturers - General names. JNJ ranks #1 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
35,436 | $8,999,679 | |
| 2 | ABBV |
AbbVie Inc.
|
30,427 | $7,656,650 | |
| 3 | LLY |
ELI LILLY & Co
|
5,375 | $6,446,935 | |
| 4 | PFE |
Pfizer Inc
|
198,256 | $4,774,004 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,213 | $2,468,870 | |
| 6 | AMGN |
Amgen Inc
|
4,464 | $1,616,503 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,158 | $904,341 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,107 | $409,504 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,999,679 | 35,436 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,491,600 | 34,739 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $9,165,608 | 44,289 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $8,747,373 | 47,176 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $8,703,235 | 56,977 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $35,706,648 | 215,308 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $19,137,392 | 132,329 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $20,064,964 | 123,812 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $16,023,075 | 109,627 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $15,768,845 | 99,683 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $14,096,404 | 89,935 | Shares | Other | 2024-02-15 | |
| 2023-09-30 | $16,726,607 | 107,394 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $17,977,118 | 108,610 | Shares | Other | 2023-11-13 | |
| 2023-03-31 | $18,094,235 | 116,737 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $19,475,308 | 110,248 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $16,621,059 | 101,745 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,690,287 | 99,658 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $16,827,452 | 94,947 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $15,499,623 | 90,604 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,467,160 | 83,388 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,010,366 | 72,905 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,865,503 | 66,112 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,496,771 | 66,697 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,054,879 | 60,820 | Shares | Sole | 2020-12-01 | |
| 2020-06-30 | $7,632,548 | 54,274 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $6,625,604 | 50,527 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||